Lacosamide for refractory trigeminal neuralgia and other facial pain-Case report.

Author: MasrourShamin

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To demonstrate effect of lacosamide monotherapy in three patients with refractory facial pain of various etiologies. BACKGROUND: Many medications used to treat trigeminal neuralgia and other facial pain, including first- and second-generation anticonvulsants, are often ineffective or hav...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/head.14367

データ提供:米国国立医学図書館(NLM)

Lacosamide: A Potential Treatment for Refractory Facial Pain

This research explores the efficacy of lacosamide, a third-generation anticonvulsant, in treating refractory facial pain, particularly trigeminal neuralgia. The authors present three case reports of patients with facial pain of various etiologies who experienced significant pain relief after treatment with lacosamide monotherapy. The study suggests that lacosamide may be an effective alternative treatment for patients who do not respond or tolerate standard treatments for facial pain.

Lacosamide: A Potential New Weapon in the Fight Against Facial Pain

This research offers hope for patients suffering from refractory facial pain, particularly trigeminal neuralgia. The study's findings suggest that lacosamide may provide effective pain relief for patients who haven't found success with traditional treatments.

Managing Facial Pain: Seeking Specialized Care

Facial pain can be debilitating and have a significant impact on quality of life. If you experience facial pain, it's crucial to seek professional medical care for proper diagnosis and treatment. This research highlights a potential new treatment option for refractory facial pain, offering hope for patients seeking relief.

Dr.Camel's Conclusion

This research, like a cool breeze blowing across the hot desert sands, offers a refreshing perspective on the treatment of refractory facial pain. Lacosamide, with its potential for effective pain relief, holds promise for a brighter future for patients seeking relief from this challenging condition.

Date :
  1. Date Completed 2022-10-28
  2. Date Revised 2022-12-02
Further Info :

Pubmed ID

35852085

DOI: Digital Object Identifier

10.1111/head.14367

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.